Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
A-T heterozygotes seem to have an increased risk but its size is unknown
| The first 150 words of the full text of this article appear below. |
Genetic predisposition accounts for 5-10% of breast
cancer, and two genes
BRCA1 and BRCA2
have attracted most attention
as high risk factors.1 However, these two genes probably
account for only a small proportion of the genetic risk while other
more common but less penetrant genes may explain the remainder of
genetically predisposed breast cancers.2 One such
candidate is the gene, ATM, mutated in the human genetic disorder
ataxia-telangiectasia (A-T).3 A-T heterozygotes (estimated
to be 1% of the population) do not show any of the major symptoms of
the disease, though there is good evidence that they have an underlying
cellular radiosensitivity, but to a lesser extent than observed in A-T
homozygotes.4 These observations, together with earlier
epidemiological studies, reveal a raised incidence of mortality from
cancer among blood relations of patients with ataxia-telangiectasia,
with the greatest relative risk for breast cancer (5.1) in female
relatives of patients.5
An association between
Read all Rapid Responses